# TTT Versus TTT and Triamcinolone to Decrease Exudation in Choroidal Melanoma After Proton Beam Therapy

> **NCT02379000** · PHASE4 · UNKNOWN · sponsor: **Charite University, Berlin, Germany** · enrollment: 50 (estimated)

## Conditions studied

- Exudative Retinal Detachment
- Uveal Melanoma

## Interventions

- **DRUG:** Triamcinolone Acetonide
- **PROCEDURE:** Transpupillary thermotherapy

## Key facts

- **NCT ID:** NCT02379000
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2017-12
- **Final completion:** 2018-07
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2017-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02379000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02379000, "TTT Versus TTT and Triamcinolone to Decrease Exudation in Choroidal Melanoma After Proton Beam Therapy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02379000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*